Compounds > ag 3-5
Page last updated: 2024-09-04

ag 3-5 and cannabigerol

ag 3-5 has been researched along with cannabigerol in 1 studies

Compound Research Comparison

Studies
(ag 3-5)		Trials
(ag 3-5)		Recent Studies (post-2010)
(ag 3-5)		Studies
(cannabigerol)		Trials
(cannabigerol)		Recent Studies (post-2010) (cannabigerol)
126066103389

Protein Interaction Comparison

ProteinTaxonomyag 3-5 (IC50)cannabigerol (IC50)
Inhibin alpha chainHomo sapiens (human)5.2
Cannabinoid receptor 1Homo sapiens (human)3.31
Cannabinoid receptor 2 Homo sapiens (human)3.46
Transient receptor potential cation channel subfamily M member 8Homo sapiens (human)0.16
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)2.6
Transient receptor potential cation channel subfamily M member 8Rattus norvegicus (Norway rat)0.16
Transient receptor potential cation channel subfamily V member 4Homo sapiens (human)1.3
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)1.5
Transient receptor potential cation channel subfamily V member 2Homo sapiens (human)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D1

Reviews

1 review(s) available for ag 3-5 and cannabigerol

ArticleYear
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
    Journal of medicinal chemistry, 2010, Jul-22, Volume: 53, Issue:14

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels

2010
chemdatabank.com